Cargando…

Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan

Background: With the increased availability of safe antiretroviral therapy (ART) in recent years, achieving optimal adherence and patient retention is becoming the biggest challenge for people living with HIV (PLWH). Care retention is influenced by several socioeconomic, socio-cultural, and governme...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ali, Dujaili, Juman Abdulelah, Jabeen, Musarat, Umair, Malik Muhammad, Chuah, Lay-Hong, Hashmi, Furqan Khurshid, Awaisu, Ahmed, Chaiyakunapruk, Nathorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832364/
https://www.ncbi.nlm.nih.gov/pubmed/35153763
http://dx.doi.org/10.3389/fphar.2021.807446
_version_ 1784648704290979840
author Ahmed, Ali
Dujaili, Juman Abdulelah
Jabeen, Musarat
Umair, Malik Muhammad
Chuah, Lay-Hong
Hashmi, Furqan Khurshid
Awaisu, Ahmed
Chaiyakunapruk, Nathorn
author_facet Ahmed, Ali
Dujaili, Juman Abdulelah
Jabeen, Musarat
Umair, Malik Muhammad
Chuah, Lay-Hong
Hashmi, Furqan Khurshid
Awaisu, Ahmed
Chaiyakunapruk, Nathorn
author_sort Ahmed, Ali
collection PubMed
description Background: With the increased availability of safe antiretroviral therapy (ART) in recent years, achieving optimal adherence and patient retention is becoming the biggest challenge for people living with HIV (PLWH). Care retention is influenced by several socioeconomic, socio-cultural, and government policies during the COVID-19 pandemic. Therefore, we aim to explore barriers and facilitators to adherence to ART among PLWH in Pakistan in general and COVID-19 pandemic related in particular. Methods: Semi-structured interviews were conducted among 25 PLWH from December 2020 to April 2021 in the local language (Urdu) at the ART centre of Pakistan Institute of Medical Sciences, Islamabad, Pakistan. Interviews were audio-recorded in the local Urdu language, and bilingual expert (English, Urdu) transcribed verbatim, coded for themes and sub-themes, and analyzed using a phenomenological approach for thematic content analysis. Results: Stigma and discrimination, fear of HIV disclosure, economic constraints, forgetfulness, religion (Ramadan, spiritual healing), adverse drug reactions, lack of social support, alternative therapies, and COVID-19-related lock-down and fear of lesser COVID-19 care due to HIV associated stigma were identified as barriers affecting the retention in HIV care. At the same time, positive social support, family responsibilities, use of reminders, the beneficial impact of ART, and initiation of telephone consultations, courier delivery, and long-term delivery of antiretrovirals during COVID-19 were identified as facilitators of HIV retention. Conclusion: Improving adherence and retention is even more challenging due to COVID-19; therefore, it requires the integration of enhanced access to treatment with improved employment and social support. HIV care providers must understand these reported factors comprehensively and treat patients accordingly to ensure the continuum of HIV care. A coordinated approach including different stakeholders is required to facilitate patient retention in HIV care and consequently improve the clinical outcomes of PLWH.
format Online
Article
Text
id pubmed-8832364
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88323642022-02-12 Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan Ahmed, Ali Dujaili, Juman Abdulelah Jabeen, Musarat Umair, Malik Muhammad Chuah, Lay-Hong Hashmi, Furqan Khurshid Awaisu, Ahmed Chaiyakunapruk, Nathorn Front Pharmacol Pharmacology Background: With the increased availability of safe antiretroviral therapy (ART) in recent years, achieving optimal adherence and patient retention is becoming the biggest challenge for people living with HIV (PLWH). Care retention is influenced by several socioeconomic, socio-cultural, and government policies during the COVID-19 pandemic. Therefore, we aim to explore barriers and facilitators to adherence to ART among PLWH in Pakistan in general and COVID-19 pandemic related in particular. Methods: Semi-structured interviews were conducted among 25 PLWH from December 2020 to April 2021 in the local language (Urdu) at the ART centre of Pakistan Institute of Medical Sciences, Islamabad, Pakistan. Interviews were audio-recorded in the local Urdu language, and bilingual expert (English, Urdu) transcribed verbatim, coded for themes and sub-themes, and analyzed using a phenomenological approach for thematic content analysis. Results: Stigma and discrimination, fear of HIV disclosure, economic constraints, forgetfulness, religion (Ramadan, spiritual healing), adverse drug reactions, lack of social support, alternative therapies, and COVID-19-related lock-down and fear of lesser COVID-19 care due to HIV associated stigma were identified as barriers affecting the retention in HIV care. At the same time, positive social support, family responsibilities, use of reminders, the beneficial impact of ART, and initiation of telephone consultations, courier delivery, and long-term delivery of antiretrovirals during COVID-19 were identified as facilitators of HIV retention. Conclusion: Improving adherence and retention is even more challenging due to COVID-19; therefore, it requires the integration of enhanced access to treatment with improved employment and social support. HIV care providers must understand these reported factors comprehensively and treat patients accordingly to ensure the continuum of HIV care. A coordinated approach including different stakeholders is required to facilitate patient retention in HIV care and consequently improve the clinical outcomes of PLWH. Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8832364/ /pubmed/35153763 http://dx.doi.org/10.3389/fphar.2021.807446 Text en Copyright © 2022 Ahmed, Dujaili, Jabeen, Umair, Chuah, Hashmi, Awaisu and Chaiyakunapruk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ahmed, Ali
Dujaili, Juman Abdulelah
Jabeen, Musarat
Umair, Malik Muhammad
Chuah, Lay-Hong
Hashmi, Furqan Khurshid
Awaisu, Ahmed
Chaiyakunapruk, Nathorn
Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
title Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
title_full Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
title_fullStr Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
title_full_unstemmed Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
title_short Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan
title_sort barriers and enablers for adherence to antiretroviral therapy among people living with hiv/aids in the era of covid-19: a qualitative study from pakistan
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832364/
https://www.ncbi.nlm.nih.gov/pubmed/35153763
http://dx.doi.org/10.3389/fphar.2021.807446
work_keys_str_mv AT ahmedali barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT dujailijumanabdulelah barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT jabeenmusarat barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT umairmalikmuhammad barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT chuahlayhong barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT hashmifurqankhurshid barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT awaisuahmed barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan
AT chaiyakunapruknathorn barriersandenablersforadherencetoantiretroviraltherapyamongpeoplelivingwithhivaidsintheeraofcovid19aqualitativestudyfrompakistan